Naive T Cells Find Homes in Lymphoid Tissue

The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.

Written byKaren Zusi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, NCIAt birth, the human body is brimming with naive T cells, immune cells generated in the thymus that have yet to encounter a pathogen. Production of these cells declines with age, but they persist in the body to muster an immune response against novel invaders. In a Science Immunology paper published today (December 2), Columbia University researchers explore the mechanisms behind such persistence, showing that these cell populations are sequestered in lymphoid tissue and that each lymphoid site maintains a unique set of naive T cell clones.

“It’s really nice to have this in the human and across all of these different tissues. [The authors] confirm many of the things that were established in different models,” said Janko Nikolich-Zugich, an immunologist and gerontologist at the University of Arizona who was not involved with the research. “The compartmentalization [of naive T cells] is the biggest story.”

Previous studies of immune cell populations in people relied on blood samples to pick up circulating T cells, but the Columbia team took a different approach. In partnership with an organ procurement organization in New York City called LiveOnNY, the researchers obtained donor tissue from the thymus, lymph nodes, and spleen, then analyzed the cell content.

“After the teams come to get organs for lifesaving transplantation, we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies